Cullinan Therapeutics Inc News - CGEM

Cullinan Oncology to Participate in the HC Wainwright Global Investment Conference and the Morgan Stanley Healthcare Conference

CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan...

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Cullinan Oncology Announces Appointment of Jacquelyn Sumer as Chief Legal Officer

CAMBRIDGE, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan...

Cullinan Management (CGEM) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Edward White maintained a Buy rating on Cullinan Management (CGEM - Research Report) today and set a price target of...

Quarterly Report (10-q)

http://fasb.org/us-gaap/2022#LicenseMemberYesYesfalsehttp://fasb.org/us-gaap/2022#LicenseMemberhttp://fasb.org/us-gaap/2022#LicenseMemberhttp://f...

Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Completed agreement for strategic collaboration to jointly develop and commercialize CLN-081 with Taiho...

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today...

Cullinan Oncology to Participate in BTIG Biotechnology Conference and Canaccord Growth Conference

CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Cullinan Oncology to Participate in William Blair Biotech Focus Conference

CAMBRIDGE, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) a...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Cullinan Therapeutics Inc (CGEM)

Empower your portfolio: Real-time discussions and actionable trading ideas.

CGEM News

Cullinan Oncology to Participate in the HC Wainwright Global Investment Conference and the Morgan Stanley Healthcare Conference

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Statement of Changes in Beneficial Ownership (4)

Initial Statement of Beneficial Ownership (3)

Cullinan Oncology Announces Appointment of Jacquelyn Sumer as Chief Legal Officer

Cullinan Management (CGEM) Receives a Buy from H.C. Wainwright

Quarterly Report (10-q)

Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cullinan Oncology to Participate in BTIG Biotechnology Conference and Canaccord Growth Conference

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Cullinan Oncology to Participate in William Blair Biotech Focus Conference

CGEM Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Cullinan Therapeutics Inc (CGEM) News

Cullinan Therapeutics Inc (CGEM)

Empower your portfolio: Real-time discussions and actionable trading ideas.

CGEM News

Cullinan Oncology to Participate in the HC Wainwright Global Investment Conference and the Morgan Stanley Healthcare Conference

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Statement of Changes in Beneficial Ownership (4)

Initial Statement of Beneficial Ownership (3)

Cullinan Oncology Announces Appointment of Jacquelyn Sumer as Chief Legal Officer

Cullinan Management (CGEM) Receives a Buy from H.C. Wainwright

Quarterly Report (10-q)

Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cullinan Oncology to Participate in BTIG Biotechnology Conference and Canaccord Growth Conference

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Cullinan Oncology to Participate in William Blair Biotech Focus Conference

CGEM Discussion

Your Recent History